-+ 0.00%
-+ 0.00%
-+ 0.00%
Vaxcyte launches USD 500 million convertible senior notes offering due 2032
Share
Listen to the news
Vaxcyte launches USD 500 million convertible senior notes offering due 2032
  • Vaxcyte launched an underwritten public offering of USD 500 million of convertible senior notes due 2032.
  • Notes set to mature on Oct. 15, 2032; interest rate and initial conversion rate to be fixed at pricing.
  • Underwriters have a 30-day option to buy up to an additional USD 75 million of notes to cover over-allotments.
  • Proceeds earmarked for VAX-31 clinical development, manufacturing scale-up, launch preparations, other R&D, working capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610051628PRIMZONEFULLFEED9839958) on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending